In March, the Minnesota House of Representatives passed a bill (HF 400) dealing with opioid addiction. In early April, the senate passed its version (SF 751) and the 34-page bill is now before a conference committee…the main argument lies in whether the $20 million should come from the state’s general fund or from taxing the pharmaceutical manufacturers and wholesalers.¬†Read More.

Pin It on Pinterest